戻る Agenda
Enabling Patient-Centric Clinical Studies: TransCelerate’s Patient Engagement Tools
Session Chair(s)
Mary Elmer, BSN, MSN, RN
Executive Director, Patient Engagement for Oncology
Merck & Co., Inc., United States
TransCelerate BioPharma is a collaboration of 19 of the world’s leading pharmaceutical organizations that has undertaken a Patient Experience initiative to enable greater patient engagement and partnership between patient and sponsors.
Learning Objective : Describe TransCelerate’s Patient Experience Initiative and the toolkits; Recognize the value of patient engagement in the development of clinical study protocols; Identify the clinical study participant experience as a valuable outcome measure; Appreciate the opportunity for embedding these practices into the development process.
Speaker(s)
Facilitator
Lani Hashimoto
Hashimoto Consulting Services, United States
Consultant, Patient Experience
Facilitator
Anne Marie Inglis, PHD
GSK, United States
Senior Director, Clinical Operations Asset Lead
Facilitator
Christina Cantrell, MSC
Genentech, A Member of the Roche Group, United States
Senior Patient Insights Leader